Related Experiment Video
Updated: Jun 23, 2026
09:42
Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
Published on: November 8, 2013
How to Implement Adherence-Promoting Programs in Clinical Practice? A Discrete Choice Experiment on Physicians'
Sabrina Müller1, Tjalf Ziemssen2, Curt Diehm3
1Ingress-Health, Wismar 23966, Germany.
Patient Preference and Adherence
|February 28, 2020
Summary
Physicians prioritize adherence-promoting programs (APPs) with minimal time commitment and high reimbursement. Understanding these preferences, especially time and financial incentives, is key to increasing physician engagement with APPs.
Area of Science:
- Health Services Research
- Medical Practice Management
- Patient Adherence
Background:
- Adherence-promoting programs (APPs) are crucial for improving patient outcomes.
- Physician willingness to implement APPs is influenced by program characteristics.
- Understanding these preferences is vital for designing effective APPs.
Purpose of the Study:
- To examine physicians' preferences for adherence-promoting programs (APPs).
- To identify specific APP characteristics influencing physicians' implementation decisions.
Main Methods:
- A discrete choice experiment was conducted with 222 physicians (GPs, cardiologists, neurologists, ophthalmologists) in Germany.
- Key attributes evaluated included validation status, certification, intervention type, time commitment, and reimbursement.
- A multinomial logit model analyzed attribute importance and physician utility.
Main Results:
- Time commitment (34.8%) and reimbursement (33.3%) were the most significant factors influencing physician choice.
- Physicians preferred APPs with low time commitment, high reimbursement, and positive validation status.
- Other factors like certification (4.7%) and intervention type (3.6%) had less impact.
Conclusions:
- Physician willingness to adopt APPs is primarily driven by time commitment and reimbursement.
- Tailoring APP features to physician preferences can enhance program uptake and engagement.
- Considering these factors in APP design is essential for successful implementation.
Keywords:
adherence interventionsadherence promoting programscompliance programsdiscrete choice experimentMore Related Videos
06:28E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
13:20Online Repetitive Transcranial Magnetic Stimulation of Dorsomedial and Dorsolateral Prefrontal Cortex in Cognition Decision Making, and Cognitive Dissonance
Published on: December 5, 2025
Related Concept Videos
02:07Blind Procedures
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
01:16Crossover Experiments
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
01:30Ethical Dilemmas II
Resolving an ethical dilemma in healthcare involves a systematic approach that considers every aspect of the issue, respecting both the patient's needs and values and the healthcare professional's ethical obligations. Here are potential steps to resolve an ethical dilemma:
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...